Seeking Alpha

jetpilotdan

jetpilotdan
Send Message
View as an RSS Feed
View jetpilotdan's Comments BY TICKER:
Latest  |  Highest rated
  • Mast Therapeutics to buy blood-pressure firm Aires [View news story]
    Will Novartis partner up with mstx now that air001 can complete phase 2 & 3 goals?
    Sep 14, 2014. 12:20 PM | Likes Like |Link to Comment
  • Mast Therapeutics' MST-188 Would Fit Well In Merck's Drug Development Pipeline [View article]
    What do you think the PPS for MSTX will be by the end of 2015?
    Aug 3, 2014. 02:30 PM | Likes Like |Link to Comment
  • Mast Pharmaceuticals Inc.: Breakthrough Drug MST-188 Could Lead To Huge Gains [View article]
    Any news of MSTX ali phase 2 startup news?
    Mar 25, 2014. 01:30 AM | Likes Like |Link to Comment
  • Mast Pharmaceuticals Inc.: Breakthrough Drug MST-188 Could Lead To Huge Gains [View article]
    I think of DARPA funding MST-188 for our troops surving battlefield injuries.
    Jan 25, 2014. 10:51 PM | Likes Like |Link to Comment
  • Mast Pharmaceuticals Inc.: Breakthrough Drug MST-188 Could Lead To Huge Gains [View article]
    Good article.

    There are lots of stock bashers on this & on the MSTX Yahoo message board. There is no more stock dilution coming. This stock is way undervalued & good news coming for 2014. The PPS IMO will be $10 by the end of 2014 with partnerships & government grants for MST-188.
    Jan 22, 2014. 01:40 PM | Likes Like |Link to Comment
  • Mast Therapeutics: A Hidden Gem In An Under-served Market [View article]
    Waiting for $3 PPS.
    Nov 18, 2013. 06:28 PM | Likes Like |Link to Comment
  • Mast Therapeutics, Inc.: A Swing Traders Play Too [View instapost]
    What do you think the long term price of MSTX would be? Also it looks like ANX-514 got its patent approval. Do you think they will finish development of that drug too?
    Sep 24, 2013. 08:08 AM | Likes Like |Link to Comment
  • Adventrx Pharmaceuticals: Why It Is Worth Over $5 Per Share [View article]
    Yes your are correct. Also ANX-514 was approved by the us patent office. MSTX has till October 17th to pay the filing fee.

    I expect MSTX to develop, sell or partner up.
    Aug 17, 2013. 09:48 AM | Likes Like |Link to Comment
  • Mast Therapeutics (MSTX +1.4%) gains today after the European Commission granted orphan-drug designation to it's MST-188 drug candidate, a potential treatment for sickle cell disease. The decision gives MSTX 10 years of marketing exclusivity, and follows a similar positive opinion by the Committee for Orphan Medicinal Products. The company says it expects to now pursue strategic alliances "more aggressively." [View news story]
    Next event should be a business partnership.
    Mar 25, 2013. 02:34 PM | Likes Like |Link to Comment
  • 3 Micro-Caps With Sustainable Cash Flows [View article]
    Whenever ANX gives out future good news, good testing results or a partnership with ANX-188 the stock will go up.
    Feb 17, 2013. 07:22 PM | Likes Like |Link to Comment
  • ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188 [View article]
    It's finally started. IMO $10 PPS in 1 year with short approval.
    Jan 30, 2013. 03:08 PM | Likes Like |Link to Comment
  • Adventrx Pharmaceuticals: Why It Is Worth Over $5 Per Share [View article]
    Vista Partners today gave ANX a target price of $4.50 a share. Waiting for the ANX-188 phase 3 trial schedule and futher details.
    Nov 6, 2012. 05:46 PM | 1 Like Like |Link to Comment
  • Adventrx Pharmaceuticals: Why It Is Worth Over $5 Per Share [View article]
    Read the ANX phase 3 testing news today. Up in after hours trading.
    Oct 25, 2012. 06:55 PM | Likes Like |Link to Comment
  • Adventrx Pharmaceuticals: Why It Is Worth Over $5 Per Share [View article]
    This stock will be undead when phase 3 testing begins. ANX says testing will begin before the end of 2012. Time will prove you right or wrong.
    Oct 20, 2012. 04:43 PM | 1 Like Like |Link to Comment
  • Adventrx Pharmaceuticals: Why It Is Worth Over $5 Per Share [View article]
    Time will show us the truth.
    Oct 16, 2012. 08:50 AM | Likes Like |Link to Comment
COMMENTS STATS
25 Comments
8 Likes